Novocure's Pancreatic Breakthrough: 53% Stock Surge Signals A Platform Turning Point!
Novocure has secured a pivotal regulatory win with the U.S. Food and Drug Administration approving Optune Pax for the treatment of locally...
204 Views
Zai Lab Follow-On Offering - Much Better Liquidity and Strong Track Record than a Year Ago
Zai Lab Ltd (ZLAB US) is looking to raise up to US$750m in its follow-on offering. Track record and liquidity has improved significantly since then.
481 Views
No more insights